Brief: Edesa Biotech Inc - For The Quarter Ended March 31, 2022, Co Reported A Net Loss Of $4.57 Million, Or $0.33 Per Common Share

Edesa Biotech

13/05/2022 14:06

May 13 (Reuters) - Edesa Biotech Inc  EDSA.O :
    * EDESA BIOTECH INC - FOR THE QUARTER ENDED MARCH 31, 2022,
EDESA
REPORTED A NET LOSS OF $4.57 MILLION, OR $0.33 PER COMMON SHARE

Further company coverage:  EDSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))